NUVB
USDNuvation Bio Inc. Class A Common Stock
Precio en Tiempo Real
Gráfico de Precios
Métricas Clave
Métricas de Mercado
Apertura
$5.150
Máximo
$5.190
Mínimo
$3.920
Volumen
6.20M
Fundamentos de la Empresa
Capitalización de Mercado
1.7B
Industria
Biotecnología
País
United States
Estadísticas de Negociación
Volumen Promedio
7.11M
Bolsa
NYQ
Moneda
USD
Rango de 52 Semanas
Noticias Relacionadas
RBC Capital Maintains Outperform on Nuvation Bio, Raises Price Target to $8
RBC Capital analyst Leonid Timashev maintains Nuvation Bio with a Outperform and raises the price target from $7 to $8.
Nuvation Bio Reports Third Quarter 2025 Financial Results and Provides Business Update
Successfully started 204 patients on IBTROZI™ (taletrectinib) in the third quarter of 2025 Updated data continue to show IBTROZI's unprecedented durability in TKI-naïve, advanced ROS1-positive (ROS1+) non-small
Nuvation Bio to Participate in Upcoming Investor Conferences
Nuvation Bio Inc. (NYSE:NUVB), a global oncology company focused on tackling some of the toughest challenges in cancer treatment, today announced that David Hung, M.D., Founder, President, and Chief Executive Officer of
Acciones Relacionadas
GOODN
Gladstone Commercial Corporation 6.625% Series E Cumulative Redeemable Preferred Stock
LSXMA
Liberty Media Corporation Series A Liberty SiriusXM
WHLR
Wheeler Real Estate Investment Trust Inc.
PCTY
Paylocity Holding Corporation
GREE
Greenidge Generation Holdings Inc.
Mantente Actualizado
Configura alertas de precio, recibe actualizaciones de análisis de IA y noticias de mercado en tiempo real.